Pfizer (PFE) announced on Friday that the U.S. Food and Drug Administration granted priority review for a marketing ...

The U.S. Food and Drug Administration issued its full approval of the Pfizer covid-19 vaccine Monday. The move comes eight months after the Pfizer vaccine was authorized for emergency use in the ...

Pfizer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Hympavzi hemophilia drug for two patient populations with significant medical need ...

The Food and Drug Administration announced Monday that it has granted full approval to Pfizer and BioNTech for their COVID-19 vaccine to be given to Americans as young as 16, clearing the way for a ...

Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...

The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, a milestone that could lift public confidence in the shots and spur more companies, universities and local governments to make ...

Stream Connecticut News for free, 24/7, wherever you are. The new vaccines, which target the omicron variant XBB.1.5, are approved for people 12 and older and are authorized under emergency use for ...

PHILADELPHIA (WPVI) -- The FDA has authorized the Pfizer vaccine for kids ages 12 to 15. The CDC still has to give its stamp of approval, but if everything goes as expected, we could see more kids in ...

With the full FDA approval of the Pfizer COVID-19 vaccine, many across the country are asking questions. Will this be a reason for more employers and schools to begin mandating vaccination? What sort ...

The U.S. Food and Drug Administration will decide on full approval of the Pfizer-BioNTech COVID-19 vaccine by January 2022. Pfizer announced on Friday that the FDA granted their request for primary ...

The US Food and Drug Administration (FDA) has approved a label change to Pfizer’s injectable contraceptive, Depo-Provera (medroxyprogesterone acetate), which will warn users of their increased risk of ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.